Newsletter Archive

91. 09.19.18 -- Manual Aseptic Processing: The Last Resort Or The Best Approach?
    9/19/2018
    09/19/18 BioProcess Online Newsletter
92. 09.18.18 -- Strategic Considerations In Drug Development
    9/18/2018
    09/18/18 BioProcess Online Newsletter
93. 09.17.18 -- Education vs. Experience: What's More Important In Biopharma Operations?
    9/17/2018
    09/17/18 BioProcess Online Newsletter
94. 09.12.18 -- Brexit: The Good, The Bad, And The Chaos
    9/12/2018
    09/12/18 BioProcess Online Newsletter
95. 09.11.18 -- Automation Drives Flexibility And Efficiency For Fujifilm Diosynth Biotechnologies
    9/11/2018
    09/11/18 BioProcess Online Newsletter
96. 09.10.18 -- FDA And Quality Metrics: Where Do Things (Currently) Stand?
    9/10/2018
    09/10/18 BioProcess Online Newsletter
97. 09.05.18 -- Is Obsolescence The Best Biosimilar Defense?
    9/5/2018
    09/05/18 BioProcess Online Newsletter
98. 08.29.18 -- 9 Challenges Keeping Cell And Gene Therapy Executives Up At Night
    8/29/2018
    08/29/18 BioProcess Online Newsletter
99. 08.27.18 -- A 6-Step Process To Assess Risk And Benefit In ICH Q9 Decision Making
    8/27/2018
    08/27/18 BioProcess Online Newsletter
100. 08.22.18 -- FDA's New Guidance On Replication Competent Retrovirus Testing During Gene Therapy Manufacture
     8/22/2018
     08/22/18 BioProcess Online Newsletter